Tc Biopharm - Adr

CUSIP 87807D509COMQ2 2025

Tc Biopharm - Adr — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

5.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

1 filings · latest Nov 14, 2024

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Nov 14, 2024	Armistice Capital, LLC	13G/A	5.0%	27.8K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Rhumbline Advisers	173	$34